Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
10.2M
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
100K
-
Shares change
-
-3.68K
-
Total reported value, excl. options
-
$329K
-
Value change
-
+$12.1K
-
Number of buys
-
9
-
Number of sells
-
-11
-
Price
-
$3.28
Significant Holders of Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share (BNGO) as of Q2 2025
31 filings reported holding BNGO - Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2025.
Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share (BNGO) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 100K shares
of 10.2M outstanding shares and own 0.99% of the company stock.
Largest 10 shareholders include GSA CAPITAL PARTNERS LLP (40.1K shares), GEODE CAPITAL MANAGEMENT, LLC (18.9K shares), MORGAN STANLEY (11.7K shares), BlackRock, Inc. (9.94K shares), BANK OF AMERICA CORP /DE/ (8.41K shares), OSAIC HOLDINGS, INC. (3.2K shares), UBS Group AG (2.67K shares), Tower Research Capital LLC (TRC) (2.31K shares), GROUP ONE TRADING LLC (1.53K shares), and SUMMIT SECURITIES GROUP LLC (1.2K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.